Fate Therapeutics News

Fate Therapeutics | 10-Q: Quarterly report

May 10 04:09

Fate Therapeutics | 8-K: Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

May 10 04:08

Fate Therapeutics | 8-K: Current report

May 9 21:02

Fate Therapeutics | 424B3: Prospectus

May 3 04:05

Fate Therapeutics | EFFECT: Others

Apr 30 18:11

Fate Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:35

Fate Therapeutics | DEFA14A: Others

Apr 27 04:28

Fate Therapeutics | ARS: Annual Report to Security Holders

Apr 27 04:23

Fate Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 19 04:03

Fate Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:11

Fate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Redmile Group, LLC

Mar 26 09:35

Fate Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(14.9%),Jeremy C. Green(14.9%), etc.

Mar 26 05:20

Fate Therapeutics | 8-K: Current report

Mar 22 02:52

Fate Therapeutics | 424B5: Prospectus

Mar 21 05:33

Fate Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dulac Edward J III

Mar 6 05:30

Fate Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 5 02:30

Fate Therapeutics | 10-K: Annual report

Feb 27 05:18

Fate Therapeutics | 8-K: Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Feb 27 05:09

Fate Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.43%)

Feb 14 07:05

Fate Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Boxer Capital, LLC(6.3%),Boxer Asser Management Inc.(6.3%), etc.

Feb 13 07:10